Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S del Barco

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 7, 2013
[Possible interaction between exemestane and clopidogrel]S del Barco, N Quer, S Guerra, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 28, 2013
SEOM clinical guidelines for the systemic treatment of early breast cancer 2013S Del Barco, E Ciruelos, I Tusquets, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 4, 2018
Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patientsB Losada, J A Guerra, D Malón, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathyA Vazquez-Martin, C Oliveras-Ferraros, S del Barco, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2013
Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guidelineM J Gil-Gil, M Martinez-Garcia, A Sierra, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 1, 2022
Expert consensus to optimize the treatment of elderly patients with luminal metastatic breast cancerM D Torregrosa-Maicas, S Del Barco-Berrón, A Cotes-Sanchís, et al.
Breast Cancer Research and Treatment|October 23, 2008
Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trialS Del Barco, R Colomer, L Calvo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2009
Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical-translational research experience at the Catalan Institute of OncologyB Martin-Castillo, J Dorca, A Vazquez-Martin, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 12, 2017
SEOM clinical guideline for treatment of cancer pain (2017)C Jara, S Del Barco, C Grávalos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 8, 2018
Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimensI Blancas, E Aguirre, S Morales, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 7, 2013
[Possible interaction between exemestane and clopidogrel]S del Barco, N Quer, S Guerra, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 28, 2013
SEOM clinical guidelines for the systemic treatment of early breast cancer 2013S Del Barco, E Ciruelos, I Tusquets, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 4, 2018
Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patientsB Losada, J A Guerra, D Malón, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathyA Vazquez-Martin, C Oliveras-Ferraros, S del Barco, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2013
Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guidelineM J Gil-Gil, M Martinez-Garcia, A Sierra, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 1, 2022
Expert consensus to optimize the treatment of elderly patients with luminal metastatic breast cancerM D Torregrosa-Maicas, S Del Barco-Berrón, A Cotes-Sanchís, et al.
Breast Cancer Research and Treatment|October 23, 2008
Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trialS Del Barco, R Colomer, L Calvo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2009
Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical-translational research experience at the Catalan Institute of OncologyB Martin-Castillo, J Dorca, A Vazquez-Martin, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 12, 2017
SEOM clinical guideline for treatment of cancer pain (2017)C Jara, S Del Barco, C Grávalos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 8, 2018
Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimensI Blancas, E Aguirre, S Morales, et al.
Pageof 2